Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
- 30 June 2020
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (4), 273-276
- https://doi.org/10.1016/j.dsx.2020.04.001
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJama-Journal Of The American Medical Association, 2020
- Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-AnalysesJournal of Medical Internet Research, 2020
- Clinical considerations for patients with diabetes in times of COVID-19 epidemicDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- "Diabetes care at doorsteps": A customised mobile van for the prevention, screening, detection and management of diabetes in the urban underprivileged populations of DelhiDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Interactive telemedicine: effects on professional practice and health care outcomesCochrane Database of Systematic Reviews, 2015
- Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes MellitusMedicine, 2014
- Telemedicine and tele-health services for cancer-care delivery in IndiaIET Communications, 2008